Duodenal exclusion devices: promising tools in treating obesity and type 2 diabetes

被引：4
|
作者：
Cummings, Bethany P. [1 ]
机构：
[1] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA
来源：
GUT | 2014年 / 63卷 / 08期
关键词：
BARIATRIC SURGERY; GLUCOSE; WEIGHT; BYPASS;
D O I：
10.1136/gutjnl-2013-306040
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1201 / U23
页数：2
相关论文
共 50 条
  • [1] Perspectives on interventional diabetology: Duodenal exclusion is promising for human type 2 diabetes mellitus remission
    Ting, Ching-Heng
    Syu, Yu-Fong
    Chen, Liang-Yu
    Lee, Fa-Yauh
    Lee, Shou-Dong
    Lee, Wei-Jei
    Chen, Chih-Yen
    NUTRITION, 2016, 32 (01) : 141 - 145
  • [2] Validation of duodenal targeting by oral pharmacologic duodenal exclusion therapy for treatment of type 2 diabetes
    Carlson, T.
    Nimgaonkar, A.
    Guerina, T.
    Colbert, K.
    Polomoscanik, S.
    Petersen, J.
    Jozefiak, T.
    Fineman, M.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S102 - S102
  • [3] Duodenal Targeting by Oral Pharmacologic Duodenal Exclusion Therapy for Treatment of Type 2 Diabetes (T2D)
    Nimgaonkar, Ashish
    Bryant, Christine
    Carlson, Taylor
    Guerina, Florence V.
    Colbert, Kevin
    Polomoscanik, Steven
    Petersen, John S.
    Jozefiak, Thomas H.
    Fineman, Mark
    DIABETES, 2023, 72
  • [4] Novel GIPR Antagonists for Treating Obesity and Type 2 Diabetes Mellitus
    Sabnis, Ram W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (12): : 2091 - 2092
  • [5] Current Perspectives for Treating Adolescents with Obesity and Type 2 Diabetes: A Review
    Niechcial, Elzbieta
    Wais, Paulina
    Bajtek, Jan
    Kedzia, Andrzej
    NUTRIENTS, 2024, 16 (23)
  • [6] Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes
    Bailey, Clifford J.
    Flatt, Peter R.
    PEPTIDES, 2024, 174
  • [7] Approaches to treatment of pre-diabetes and obesity and promising new approaches to type 2 diabetes
    Bloomgarden, Zachary T.
    DIABETES CARE, 2008, 31 (07) : 1461 - 1466
  • [8] Metabolic control of myofibers: promising therapeutic target for obesity and type 2 diabetes
    Duan, Yehui
    Li, Fengna
    Tan, Bie
    Yao, Kang
    Yin, Yulong
    OBESITY REVIEWS, 2017, 18 (06) : 647 - 659
  • [9] Endocrine effects of duodenal-jejunal exclusion in obese patients with type 2 diabetes mellitus
    Kavalkova, Petra
    Mraz, Milos
    Trachta, Pavel
    Klouckova, Jana
    Cinkajzlova, Anna
    Lacinova, Zdenka
    Haluzikova, Denisa
    Benes, Marek
    Vlasakova, Zuzana
    Burda, Vaclav
    Novak, Daniel
    Petr, Tomas
    Vitek, Libor
    Pelikanova, Terezie
    Haluzik, Martin
    JOURNAL OF ENDOCRINOLOGY, 2016, 231 (01) : 11 - 22
  • [10] Treating obesity in type a diabetes - Calories, composition, and control
    Gumbiner, B
    DIABETES CARE, 1999, 22 (06) : 886 - 888
12345